ConductScience.org, home
A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
API referenceFor AI assistants

Trial · NCT04182204

Adverse events620

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 620

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersStage 1: Pola-R-GemOx2152
otherAnaemiaBlood and lymphatic system disordersStage 2: R-GemOx3212554
otherAnaemiaBlood and lymphatic system disordersStage 2: Pola-R-GemOx48128101
otherAnaemiaBlood and lymphatic system disordersPola-R-GemOx - Pooled50143103
otherLeukocytosisBlood and lymphatic system disordersStage 1: Pola-R-GemOx1151
otherLeukocytosisBlood and lymphatic system disordersStage 2: R-GemOx41255
otherLeukocytosisBlood and lymphatic system disordersStage 2: Pola-R-GemOx21282
otherLeukocytosisBlood and lymphatic system disordersPola-R-GemOx - Pooled31433
otherLeukopeniaBlood and lymphatic system disordersStage 1: Pola-R-GemOx0150
otherLeukopeniaBlood and lymphatic system disordersStage 2: R-GemOx1012514
otherLeukopeniaBlood and lymphatic system disordersStage 2: Pola-R-GemOx412814
otherLeukopeniaBlood and lymphatic system disordersPola-R-GemOx - Pooled414314
otherLymphopeniaBlood and lymphatic system disordersStage 1: Pola-R-GemOx1151
otherLymphopeniaBlood and lymphatic system disordersStage 2: R-GemOx01250
otherLymphopeniaBlood and lymphatic system disordersStage 2: Pola-R-GemOx31283
otherLymphopeniaBlood and lymphatic system disordersPola-R-GemOx - Pooled41434
otherNeutropeniaBlood and lymphatic system disordersStage 1: Pola-R-GemOx3156
otherNeutropeniaBlood and lymphatic system disordersStage 2: R-GemOx2212549
otherNeutropeniaBlood and lymphatic system disordersStage 2: Pola-R-GemOx2412871
otherNeutropeniaBlood and lymphatic system disordersPola-R-GemOx - Pooled2714377

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04182204/events

API referenceFor AI assistants